Delivery Order 36F79719D0247-36C26024F0587
Award Date
8/15/24
Potential Completion Date
10/15/24
Potential Value
$93K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Ucb, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a delivery order contract valued at $65,982.84 to UCB, Inc. for the pharmaceutical drug ZilbrysQ. This delivery order is placed against a larger Blanket Purchase Agreement (BPA) held by UCB, Inc. with the VA National Acquisition Center, which has a total ceiling value of $264,295.45. UCB, Inc. is a global biopharmaceutical company that focuses on neurology and immunology disorders. The contract is a firm fixed-price arrangement with an...
This federal contract award is a Blanket Purchase Agreement (BPA) call for pharmaceutical products issued by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The contract has a ceiling value of $99,785.07 and a completion date of September 28, 2017. The contract is a firm fixed-price agreement under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs. This contract facilitates the procurement of critical...
<p>This is a Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of Veterans Affairs (VA) to Eisai Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract is for express pharmacy ordering of pharmaceuticals for fiscal year 2017 and has a ceiling value of $136,596.21. The contract is not set aside and is under the VA's Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB) vehicle. The place of performance is Westwood, New Jersey.</p>
This is a federal contract award to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer, by the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $84,648.41 and is a delivery order under the VA's Federal Supply Schedule (FSS-61-IB) for pharmaceuticals and drugs. It is for the supply of UPTRAVI, a specialized medication primarily used to treat pulmonary arterial hypertension. The contract does not have a set-aside designation, indicating Actelion...
This federal contract award, valued at $93,241.75, was issued by the Veterans Integrated Service Network 6 (VISN 6), a component of the U.S. Department of Veterans Affairs (VA), to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The contract is a Blanket Purchase Agreement (BPA) call under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which allows for the streamlined procurement of specialized pharmaceutical products. The contract is for...
This federal contract award was made by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The contract, valued at $24,306.90, is a Blanket Purchase Agreement (BPA) call order under Acorda's existing Federal Supply Schedule (FSS) contract with the VA. The FSS contract, valued at over $16.3 million, allows the VA to procure Acorda's pharmaceutical products, including medications used to treat Parkinson's...
This federal contract award is a firm fixed-price delivery order issued by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The contract, valued at $485,835.00, is for the supply of DALFAMPRIDINE 100 MG, a medication used to treat Parkinson's disease and multiple sclerosis symptoms. The contract was awarded on January 17, 2017, with a final completion date of...
This federal contract award, valued at $5,508.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, specifically Zeposia 0.23-0.46-0.92 MG KIT UU 37S. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables the...
This federal contract award, valued at $98,745.48, was issued by the Veterans Integrated Service Network 20, a component of the U.S. Department of Veterans Affairs (VA), to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The contract is a delivery order under Actelion's existing Federal Supply Schedule (FSS-61-IB) contract with the VA, which has a total potential value of $219,108,390 from August 2024 to July 2029. This delivery order is for the provision of...
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Acorda Therapeutics, Inc., a biotechnology company specializing in therapies for neurological disorders. The contract, valued at $478,860.00, is for the supply of DALFAMPRIDINE, a medication used to treat Parkinson's disease and multiple sclerosis. The delivery order was placed under Acorda's existing Federal Supply Schedule (FSS) contract with the VA (36F79723D0194), valued at over $16.3...